Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dialysis and Psoriasis

Dialysis and Psoriasis Abstract To the Editor.— We read with interest the letter to the editor "Treatment of Psoriasis With Dialysis" by Dr Anderson in the June 1978 issue of the Archives (114:966), as well as the related article in the Annals of Internal Medicine. Our experience has been similar to his. Although some of our patients' conditions have remained clear for prolonged periods of time, the conditions of others have not responded.1,2 We have also noted rapid recurrence (six weeks) after dialysis therapy and the remission of psoriasis with associated arthritis after cardiopulmonary bypass oxygenation.3To the studies which Dr Anderson suggested, we would like to add the use of hemodialysis and monitors of the immune mechanisms involved. Since psoriasis is a disease of epidermal proliferation, dermal hypervascularization, early mononuclear infiltration, and, finally, late neutrophil invasion, it may well be that substances elaborated by these invading cells modulate the epidermal proliferation. References 1. Buselmeier TJ, Dahl MV, Cantieri JS, et al: Treatment of psoriasis with dialysis . Proc Eur Dial Transplant Assoc , to be published. 2. Buselmeier TJ: Dialysis and psoriasis . Ann Intern Med 88:842, 1978.Crossref 3. Buselmeier TJ, Cantieri JS, Dahl MV, et al: Clearing of psoriasis after cardiac surgery requiring cardiopulmonary bypass oxygenation: A corollary to clearance after dialysis? Br J Dermatol , to be published. 4. Kreuger GG, Jederberg WW: Inhibition of monocyte chemotaxis with sera from the benign proliferative disorder psoriasis . J Clin Res 25:363A-365A, 1977. 5. Reese DL, Kreuger GG, Jederberg WW: Chemotaxis of monocytes in psoriatic subjects undergoing photochemotherapy . Clin Res 25:101A-103A, 1977. 6. Greene WH, Casann R, Mauer SM, et al: The effect of hemodialysis on neutrophil chemotactive responsiveness . J Lab Clin Med 22:981-983, 1976. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Dialysis and Psoriasis

Buselmeier, T. J.; Cantieri, John S.
Archives of Dermatology , Volume 115 (3) – Mar 1, 1979
Download PDF
1 page

Dialysis and Psoriasis

Abstract

Abstract To the Editor.— We read with interest the letter to the editor "Treatment of Psoriasis With Dialysis" by Dr Anderson in the June 1978 issue of the Archives (114:966), as well as the related article in the Annals of Internal Medicine. Our experience has been similar to his. Although some of our patients' conditions have remained clear for prolonged periods of time, the conditions of others have not responded.1,2 We have also noted rapid recurrence (six weeks)...
Loading next page...
 
/lp/american-medical-association/dialysis-and-psoriasis-FvQjRQXiZp

References (6)

Publisher
American Medical Association
Copyright
Copyright © 1979 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1979.04010030068033
Publisher site
See Article on Publisher Site

Abstract

Abstract To the Editor.— We read with interest the letter to the editor "Treatment of Psoriasis With Dialysis" by Dr Anderson in the June 1978 issue of the Archives (114:966), as well as the related article in the Annals of Internal Medicine. Our experience has been similar to his. Although some of our patients' conditions have remained clear for prolonged periods of time, the conditions of others have not responded.1,2 We have also noted rapid recurrence (six weeks) after dialysis therapy and the remission of psoriasis with associated arthritis after cardiopulmonary bypass oxygenation.3To the studies which Dr Anderson suggested, we would like to add the use of hemodialysis and monitors of the immune mechanisms involved. Since psoriasis is a disease of epidermal proliferation, dermal hypervascularization, early mononuclear infiltration, and, finally, late neutrophil invasion, it may well be that substances elaborated by these invading cells modulate the epidermal proliferation. References 1. Buselmeier TJ, Dahl MV, Cantieri JS, et al: Treatment of psoriasis with dialysis . Proc Eur Dial Transplant Assoc , to be published. 2. Buselmeier TJ: Dialysis and psoriasis . Ann Intern Med 88:842, 1978.Crossref 3. Buselmeier TJ, Cantieri JS, Dahl MV, et al: Clearing of psoriasis after cardiac surgery requiring cardiopulmonary bypass oxygenation: A corollary to clearance after dialysis? Br J Dermatol , to be published. 4. Kreuger GG, Jederberg WW: Inhibition of monocyte chemotaxis with sera from the benign proliferative disorder psoriasis . J Clin Res 25:363A-365A, 1977. 5. Reese DL, Kreuger GG, Jederberg WW: Chemotaxis of monocytes in psoriatic subjects undergoing photochemotherapy . Clin Res 25:101A-103A, 1977. 6. Greene WH, Casann R, Mauer SM, et al: The effect of hemodialysis on neutrophil chemotactive responsiveness . J Lab Clin Med 22:981-983, 1976.

Journal

Archives of Dermatology – American Medical Association

Published: Mar 1, 1979

There are no references for this article.